English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: Neoadjuvant chemotherapy can cause certain damage to patients’ physiological function.Therefore, we suspected that the sensitivity to propofol would also be altered by neoadjuvant chemotherapy.We aimed to compare the ED50 for inducing loss of consciousness (LOC) in patients with and withoutpreoperative neoadjuvant chemotherapy.Methods: Sixty-two patients were randomized to receive neoadjuvant chemotherapy (group N) or not(group C) 10 to 15 days before elective modify radical mastectomy. The up-down method was used todetermine the ED50 of propofol. Patients in each group received an initial dose of 4.0 μg/mL of propofoland a variable dose (increments or decrements) of 0.4 μg/mL of propofol based on the effective or ineffectiveresponse of the prior patient. The effective dose of propofol for induction of LOC in 50% patients wascalculated and compared.Results: The EC50 and 95% confidence intervals (95%CI) of propofol in the two groups were 3.27 μg/mL(95%CI, 3.093.43 μg/mL) and 3.33μg/mL (95%CI, 3.193.47 μg/mL) for patients undergoing electivemodified radical mastectomy with and without neoadjuvant chemotherapy respectively. Thus, there was nodifference in the EC50s between the two groups, P = 0.55.Conclusions: Under the condition of this study, we found the EC50s of propofol for induction of LOC were3.27 and 3.33 μg/mL for patients undergoing elective modified radical mastectomy in the presence orabsence of neoadjuvant chemotherapy. We do not recommend reducing the dose of propofol for inductionof LOC in patients with neoadjuvant chemotherapy.

clinical oncology and research

Neoadjuvant Chemotherapy Does Not Decrease the Dose Requirement of Propofol for Inducing the Loss of Consciousness in Patients with Breast Cancer: A Prospective Study